K231532

Substantially Equivalent

ActiGraph LEAP activity monitor (ActiGraph LEAP)

Applicant: Actigraph, LLC
Product code: LEL
Advisory panel: Neurology
Date received: 2023-05-26
Decision date: 2023-06-23
Decision: Substantially Equivalent
Clearance type: Special
Location: Pensacola, FL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.